These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 19052134

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Hepatocellular carcinoma - long-term treatable disease].
    Fínek J.
    Klin Onkol; 2012; 25(4):287-9. PubMed ID: 22920170
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Sequential therapy with sunitinib and sorafenib in metastatic hepatocellular carcinoma.
    Ahn HK, Lee S, Sun JM, Lee J, Park SH, Park JO, Park YS, Kang WK, Lim HY.
    Invest New Drugs; 2012 Aug; 30(4):1768-72. PubMed ID: 21720741
    [No Abstract] [Full Text] [Related]

  • 6. Sorafenib in advanced hepatocellular carcinoma.
    Palmer DH.
    N Engl J Med; 2008 Dec 04; 359(23):2498; author reply 2498-9. PubMed ID: 19065750
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Sorafenib: in hepatocellular carcinoma.
    Simpson D, Keating GM.
    Drugs; 2008 Dec 04; 68(2):251-8. PubMed ID: 18197728
    [Abstract] [Full Text] [Related]

  • 10. Sorafenib in hepatocellular carcinoma.
    Josephs DH, Ross PJ.
    Br J Hosp Med (Lond); 2010 Aug 04; 71(8):451-6. PubMed ID: 20852487
    [Abstract] [Full Text] [Related]

  • 11. Acute hepatitis in a patient with cirrhosis and hepatocellular carcinoma treated with sorafenib.
    Llanos L, Bellot P, Zapater P, Pérez-Mateo M, Such J.
    Am J Gastroenterol; 2009 Jan 04; 104(1):257-8. PubMed ID: 19098892
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Use of sorafenib in patients with hepatocellular or renal carcinoma].
    Rosmorduc O, Chevreau C, Dielenseger P, Ederhy S, Goldwasser F, Grange JD, Mortier L, Neidhardt-Berard ME, Robert C, Scotté F, Seitz JF.
    Gastroenterol Clin Biol; 2010 Mar 04; 34(3):161-7. PubMed ID: 20181452
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial.
    Cheng AL, Kang YK, Chen Z, Tsao CJ, Qin S, Kim JS, Luo R, Feng J, Ye S, Yang TS, Xu J, Sun Y, Liang H, Liu J, Wang J, Tak WY, Pan H, Burock K, Zou J, Voliotis D, Guan Z.
    Lancet Oncol; 2009 Jan 04; 10(1):25-34. PubMed ID: 19095497
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.